Facetten
Zugriff
Einrichtung
Medientyp
- Text 201
Karte
Erscheinungsjahr
Autor/in
- Müller, Volkmar
- Pantel, Klaus 43
- Witzel, Isabell 42
- Milde-Langosch, Karin 34
- Jänicke, Fritz 33
- alle zeigen
Sprache
201 Einträge gefunden
-
Highlights from the San Antonio Breast Cancer Symposium (SABCS) 2019
2020 - Forschungsinformationssystem des UKE -
Update Breast Cancer 2020 Part 3 - Early Breast Cancer
- Huober, Jens
- Schneeweiss, Andreas
- Hartkopf, Andreas D
- Müller, Volkmar
- Lux, Michael P
- Janni, Wolfgang
- Ettl, Johannes
-
Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer
- Tesch, Hans
- Müller, Volkmar
- Wöckel, Achim
- Ettl, Johannes
- Belleville, Erik
- Schütz, Florian
- Hartkopf, Andreas
-
-
Brain Metastasis in Breast Cancer Patients-Need for Improvement
2020 - Forschungsinformationssystem des UKE -
High homogeneity of MMR deficiency in ovarian cancer
- Fraune, Christoph
- Rosebrock, Janina
- Simon, Ronald
- Hube-Magg, Claudia
- Makrypidi-Fraune, Georgia
- Kluth, Martina
- Büscheck, Franziska
-
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
- Michel, Laura L
- Hartkopf, Andreas D
- Fasching, Peter A
- Kolberg, Hans-Christian
- Hadji, Peyman
- Tesch, Hans
- Häberle, Lothar
-
-
-
Course of cervical intraepithelial neoplasia diagnosed during pregnancy
- Grimm, Donata
- Lang, Isabelle
- Prieske, Katharina
- Jaeger, Anna
- Müller, Volkmar
- Kuerti, Sascha
- Burandt, Eike
-
-
Clinical endpoints in real-world registry studies:PRAEGNANT network for women with advanced breast cancer, Klinische Endpunkte in Real-World-Register-Studien: PRAEGNANT-Netzwerk für Patientinnen mit fortgeschrittenem Mammakarzinom
- Hartkopf, Andreas D.
- Emons, Julius
- Lux, Michael P.
- Taran, Florin Andrei
- Overkamp, Friedrich
- Tesch, Hans
- Titzmann, Adriana
-
-
-
-
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
- Stamm, Hauke
- Oliveira-Ferrer, Leticia
- Grossjohann, Eva-Maria
- Muschhammer, Jana
- Thaden, Vanessa
- Brauneck, Franziska
- Kischel, Roman
-
Immature O-glycans recognized by the macrophage glycoreceptor CLEC10A (MGL) are induced by 4-hydroxy-tamoxifen, oxidative stress and DNA-damage in breast cancer cells
- Kurze, Anna-Katharina
- Buhs, Sophia
- Eggert, Dennis
- Oliveira-Ferrer, Leticia
- Müller, Volkmar
- Niendorf, Axel
- Wagener, Christoph
-
Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?
- Kümmel, Sherko
- Jackisch, Christian
- Müller, Volkmar
- Schneeweiss, Andreas
- Klawitter, Sandra
- Lux, Michael P
-
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017: ABC4 Consensus: Assessment by a Panel of German Experts
- Untch, Michael
- Würstlein, Rachel
- Marschner, Norbert
- Lüftner, Diana
- Augustin, Doris
- Briest, Susanne
- Ettl, Johannes
-
Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
- Müller, Volkmar
- Clemens, Michael
- Jassem, Jacek
- Al-Sakaff, Nedal
- Auclair, Petra
- Nüesch, Eveline
- Holloway, Debbie